Shanghai, China

Zhongmiao Xu

This inventor holds 4 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Glaxosmithkline Intellectual Property Development Limited, Lhotse Bio, Inc. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhongmiao Xu. Retrieved from https://idiyas.com/inventor/zhongmiao-xu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 50.0

 

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Zhongmiao Xu in Pharmaceutical Development

Introduction

Zhongmiao Xu is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of pharmaceuticals. He holds a total of four patents, showcasing his innovative approach to treating various medical conditions.

Latest Patents

Among his latest patents, Zhongmiao Xu has developed compounds and compositions for treating conditions associated with LPA receptor activity. The present disclosure provides LPA antagonists, as well as pharmaceutical compositions comprising the compounds disclosed herein. Additionally, methods for treating LPA-associated diseases, disorders, and conditions are also included in his work.

Career Highlights

Zhongmiao Xu has worked with notable companies such as Lhotse Bio, Inc. and GlaxoSmithKline Intellectual Property Development Limited. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovation and development.

Collaborations

Some of his coworkers include Wei Huang and Hui Lei, who have collaborated with him on various projects, contributing to the advancement of his research and inventions.

Conclusion

Zhongmiao Xu's work in developing pharmaceutical compounds demonstrates his commitment to addressing medical challenges through innovation. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…